Arecor Therapeutics plc

AREC.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£11-£9-£11-£7
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£1
Stock-Based Comp.£0£1£1£0
Change in WC-£3£1-£2-£0
Other Non-Cash£3£1£1£1
Operating Cash Flow-£9-£6-£11-£5
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0-£8£0
Inv. Sales/Matur.£2£6£8£0
Other Inv. Act.£0£0-£8£0
Investing Cash Flow£2£7-£8-£0
Financing Activities
Debt Repay.£0£0-£0£3
Stock Issued£6£0£6£20
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£1-£0-£1-£2
Financing Cash Flow£6-£0£5£21
Forex Effect-£0-£0£0£0
Net Chg. in Cash-£2£0-£14£15
Supplemental Information
Beg. Cash£5£5£18£3
End Cash£3£5£5£18
Free Cash Flow-£9-£6-£11-£6